Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

All content curated by

Gail Hecht MD

Scott Cotler MD

Steven Edmundowicz MD, MASGE

See All Experts

Published in Gastroenterology

Journal Scan / Research · February 19, 2023

Clinical Outcomes in Patients With Biopsy-Proven NAFLD

Clinical Gastroenterology and Hepatology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Additional Info

Article Citation

Clinical Gastroenterology and Hepatology

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

Clin. Gastroenterol. Hepatol. 2023 Feb 01;21(2)370-379, H Fujii, M Iwaki, H Hayashi, H Toyoda, S Oeda, H Hyogo, M Kawanaka, A Morishita, K Munekage, K Kawata, S Yamamura, K Sawada, T Maeshiro, H Tobita, Y Yoshida, M Naito, A Araki, S Arakaki, T Kawaguchi, H Noritake, M Ono, T Masaki, S Yasuda, E Tomita, M Yoneda, N Kawada, A Tokushige, Y Kamada, H Takahashi, S Ueda, S Aishima, Y Sumida, A Nakajima, T Okanoue

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Clinical Outcomes in Patients With Biopsy-Proven NAFLD

Additional Info

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

Further Reading

Continuous Home Terlipressin Infusion Increases Hand Grip Strength and Reduces Ascites in Patients With Cirrhosis

IBD Is an Independent Risk Factor for MASLD in Lean Individuals

Over-the-Scope Clip Fixation, Endoscopic Suture Fixation, and No Fixation for Anchoring Fully Covered Self-Expanding Metal Stents in Benign Upper Gastrointestinal Conditions

Clinical Practice Guidelines on the Management of Patients With MASLD

Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH

A Machine Learning–Based, Point-of-Care Risk Calculator for Post-ERCP Pancreatitis and Prophylaxis Selection

Performance of Annual Non-Contrast Abbreviated MRI vs Biannual Ultrasound as HCC Surveillance Modalities

Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis

Association of Fecal Proteolytic Bacteria and Staphylococcal Superantigens With Abdominal Pain Severity in IBS

Assessing Dietary Emulsifier Exposure Among Patients With IBD vs Healthy Controls

A Stool DNA–Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population

Recently Updated